A dexamethasone implant improved the physiological morphology of the outer retinal layers in patients with recalcitrant diabetic macular edema (DME) associated with proliferative diabetic retinopathy, a new case series has found.
“Our results showed that dexamethasone implant has a positive outcome in terms of visual acuity improvement and [central macular thickness (CMT)] reduction, at the 6-month and at the 12-month observation, with a retreatment interval under 6 months,” the researchers write.
Pierluigi Iacono, MD, from the G.B. Bietti Foundation for Study and Research in Ophthalmology, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy, and colleagues report their findings in an article published online September 13 in the British Journal of Ophthalmology.
